Kurt Iversen

637 total citations
21 papers, 450 citations indexed

About

Kurt Iversen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kurt Iversen has authored 21 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kurt Iversen's work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Lipoproteins and Cardiovascular Health (4 papers). Kurt Iversen is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Lipoproteins and Cardiovascular Health (4 papers). Kurt Iversen collaborates with scholars based in Denmark, United States and United Kingdom. Kurt Iversen's co-authors include G. Asboe‐Hansen, T Hilden, Michael Schwartz, F Raaschou, Arne P. Skouby, Nils U. Bang, F. Carlsen, P Effersøe, J. E. Kirk and O. Dietrichson and has published in prestigious journals such as The Lancet, JAMA and Journal of Biological Chemistry.

In The Last Decade

Kurt Iversen

16 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt Iversen Denmark 10 184 91 73 71 52 21 450
James A. Bougas United States 12 106 0.6× 74 0.8× 91 1.2× 9 0.1× 42 0.8× 19 444
Sandra Jamieson United Kingdom 10 155 0.8× 173 1.9× 38 0.5× 59 0.8× 35 0.7× 13 414
Renu Virmani United States 8 376 2.0× 210 2.3× 77 1.1× 27 0.4× 53 1.0× 10 558
Nicolino Esposito Italy 11 277 1.5× 89 1.0× 121 1.7× 31 0.4× 49 0.9× 13 566
Julius L. Bedynek United States 10 182 1.0× 95 1.0× 25 0.3× 7 0.1× 63 1.2× 22 371
Per Leth-Espensen Denmark 6 71 0.4× 123 1.4× 146 2.0× 95 1.3× 23 0.4× 9 376
Wen‐Jin Cherng Taiwan 12 146 0.8× 75 0.8× 56 0.8× 14 0.2× 23 0.4× 18 367
RE Silber Germany 13 85 0.5× 203 2.2× 43 0.6× 16 0.2× 61 1.2× 25 524
W. Waas Germany 14 365 2.0× 190 2.1× 139 1.9× 20 0.3× 60 1.2× 28 687
AD Michelson United States 9 128 0.7× 199 2.2× 13 0.2× 58 0.8× 22 0.4× 12 590

Countries citing papers authored by Kurt Iversen

Since Specialization
Citations

This map shows the geographic impact of Kurt Iversen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Iversen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Iversen more than expected).

Fields of papers citing papers by Kurt Iversen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Iversen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Iversen. The network helps show where Kurt Iversen may publish in the future.

Co-authorship network of co-authors of Kurt Iversen

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Iversen. A scholar is included among the top collaborators of Kurt Iversen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Iversen. Kurt Iversen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasselbalch, Rasmus Bo, Jesper L. Kristensen, Sisse Rye Ostrowski, et al.. (2022). The impact of age on the 99th percentile of cardiac troponin. European Heart Journal. 43(Supplement_2). 1 indexed citations
2.
Nielsen, Jens, Viggo Faber, Hemming Poulsen, et al.. (1975). Acute Viral Hepatitis: A Comparative Study of Clinical, Biochemical, Morphological and Immunological Features in Patients with and without Australia Antigen. Scandinavian Journal of Infectious Diseases. 7(3). 173–177. 9 indexed citations
3.
Iversen, Kurt, et al.. (1971). BENEFITS OBTAINED BY THE INTRODUCTION OF A CORONARY‐CARE UNIT. Acta Medica Scandinavica. 189(1-6). 285–291. 39 indexed citations
4.
Hilden, T, Kurt Iversen, F Raaschou, & Michael Schwartz. (1963). Anticoagulant Therapy in Acute Myocardial Infarction. JAMA. 183(10). 903–4. 1 indexed citations
5.
Hilden, T, Kurt Iversen, F Raaschou, Michael Schwartz, & D. Vérel. (1962). EVALUATION OF ANTICOAGULANT THERAPY FOR MYOCARDIAL INFARCTION. The Lancet. 280(7264). 1056–1057.
6.
Hilden, T, Kurt Iversen, F Raaschou, & Michael Schwartz. (1962). ANTICOAGULANTS IN ACUTE MYOCARDIAL INFARCTION. The Lancet. 279(7231). 694–695. 2 indexed citations
7.
Iversen, Kurt & T Hilden. (1962). The Use of Anticoagulants in Coronary Heart Disease. Medical Clinics of North America. 46(6). 1613–1637. 6 indexed citations
8.
Hilden, T, Kurt Iversen, F Raaschou, & Michael Schwartz. (1962). ANTICOAGULANTS IN ACUTE MYOCARDIAL INFARCTION. The Lancet. 279(7244). 1411–1412. 2 indexed citations
9.
Hilden, T, Kurt Iversen, F Raaschou, & Michael Schwartz. (1961). ANTICOAGULANTS IN ACUTE MYOCARDIAL INFARCTION. The Lancet. 278(7218). 1456–1456. 1 indexed citations
10.
Hilden, T, Kurt Iversen, F Raaschou, & Michael Schwartz. (1961). ANTICOAGULANTS IN ACUTE MYOCARDIAL INFARCTION. The Lancet. 278(7206). 826–827. 1 indexed citations
11.
Hilden, T, F Raaschou, Kurt Iversen, & Michael Schwartz. (1961). ANTICOAGULANTS IN ACUTE MYOCARDIAL INFARCTION. The Lancet. 278(7198). 327–331. 168 indexed citations
12.
Bang, Nils U., et al.. (1959). Serum Glutamic‐Oxaloacetic Transaminase Activity as an Index of Centrilobular Liver Cell Necrosis in Cardiac and Circulatory Failure.. Acta Medica Scandinavica. 164(5). 385–393. 36 indexed citations
13.
Kirk, J. E., et al.. (1954). A PROCEDURE FOR DETERMINATION OF THE RESPIRATION OF AVASCULAR AND POORLY VASCULARIZED TISSUE MEMBRANES. Journal of Biological Chemistry. 208(1). 17–21. 2 indexed citations
14.
15.
Iversen, Kurt, G. Asboe‐Hansen, & F. Carlsen. (1953). ELECTRON MICROSCOPY OF CERTAIN MUSCLE LESIONS IN PATIENTS WITH PITUITARY-THYROID DISORDERS. European Journal of Endocrinology. 14(2). 177–180. 15 indexed citations
16.
Asboe‐Hansen, G., et al.. (1952). MALIGNANT EXOPHTHALMOS. European Journal of Endocrinology. 11(4). 376–399. 24 indexed citations
17.
Iversen, Kurt & G. Asboe‐Hansen. (1952). STUDIES ON THE FAT-MOBILIZING FACTOR OF THE ANTERIOR PITUITARY GLAND SUPPRESSIVE ACTION OF THYROXIN. European Journal of Endocrinology. 11(2). 111–NP. 24 indexed citations
18.
Iversen, Kurt. (1952). Acromegaly Associated with Phæochromocytoma.. Acta Medica Scandinavica. 142(1). 1–5. 31 indexed citations
19.
Iversen, Kurt. (1951). LATE RESULTS FROM CONTINUOUS TREATMENT OF THYROTOXICOSIS WITH METHYLTHIOURACIL. The Journal of Clinical Endocrinology & Metabolism. 11(3). 298–311. 15 indexed citations
20.
Asboe‐Hansen, G. & Kurt Iversen. (1951). INFLUENCE OF THYROTROPHIC HORMONE ON CONNECTIVE TISSUE PATHOGENETIC SIGNIFICANCE OF MUCOPOLYSACCHARIDES IN EXPERIMENTAL EXOPHTHALMOS. European Journal of Endocrinology. 8(1). 90–96. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James A. Bougas Breakdown of academic impact, for papers by Sandra Jamieson Breakdown of academic impact, for papers by Renu Virmani Breakdown of academic impact, for papers by Nicolino Esposito Breakdown of academic impact, for papers by Julius L. Bedynek Breakdown of academic impact, for papers by Per Leth-Espensen Breakdown of academic impact, for papers by Wen‐Jin Cherng Breakdown of academic impact, for papers by RE Silber Breakdown of academic impact, for papers by W. Waas Breakdown of academic impact, for papers by AD Michelson
Rankless by CCL
2026